Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors
出版年份 2009 全文链接
标题
Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors
作者
关键词
-
出版物
Expert Review of Neurotherapeutics
Volume 9, Issue 9, Pages 1413-1431
出版商
Informa UK Limited
发表日期
2009-09-21
DOI
10.1586/ern.09.89
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Recent developments in Alzheimer's disease therapeutics
- (2009) Michael S Rafii et al. BMC Medicine
- Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?
- (2009) Roxana Oprisiu-Fournier et al. Expert Review of Neurotherapeutics
- Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study
- (2009) Olivier Hanon et al. JOURNAL OF HYPERTENSION
- The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease
- (2009) John W Wright et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Duration of antihypertensive drug use and risk of dementia: A prospective cohort study
- (2009) M.D.M. Haag et al. NEUROLOGY
- Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons
- (2009) L. B. Hoffman et al. NEUROLOGY
- Telmisartan prevented cognitive decline partly due to PPAR-γ activation
- (2008) Masaki Mogi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
- (2008) Rachelle S Doody et al. LANCET
- Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study
- (2008) Hans-Christoph Diener et al. LANCET NEUROLOGY
- Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
- (2008) Ruth Peters et al. LANCET NEUROLOGY
- Treatment of Hypertension in Patients 80 Years of Age or Older
- (2008) Nigel S. Beckett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events
- (2008) Salim Yusuf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients
- (2008) Kenneth Jamerson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic deletion or antagonism of kinin B1 and B2 receptors improves cognitive deficits in a mouse model of Alzheimer's disease
- (2007) R.D.S. Prediger et al. NEUROSCIENCE
- Angiotensin receptor subtype mediated physiologies and behaviors: New discoveries and clinical targets
- (2007) J WRIGHT et al. PROGRESS IN NEUROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started